Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
Articles
June 13, 2024
Discover our Quality Policy
13 june, 2024
We are proud to share an unequaled level of requirement in our organization, surpassing regulatory standards to deliver excellence.
As a world leader in the healthcare industry, product quality is not just a requirement but an absolute obligation for us.
Our new Quality Policy is rooted in the foundational values of HTL Biotechnology.
It is forward-looking, embodying our leadership’s dedication 𝐭𝐨 𝐞𝐧𝐬𝐮𝐫𝐢𝐧𝐠 𝐜𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐬𝐚𝐭𝐢𝐬𝐟𝐚𝐜𝐭𝐢𝐨𝐧 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞, 𝐬𝐚𝐟𝐞, 𝐚𝐧𝐝 𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐬.
🔗
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Press releases June 5, 2025HTL Biotechnology inaugurates a new production line dedicated to sterile hyaluronic acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
-
Press releases May 27, 2025HTL Biotechnology supports National Biomedicines manufacturing Day
HTL Biotechnology is proud to support National Biomedicines manufacturing Day, which will take place on June 5, 2025.
-
Articles April 2, 2025François Fournier Featured in Korean Press
HTL Biotechnology CEO François Fournier spoke to leading Korean media DongA Ilbo, reaffirming Korea’s strategic importance and the strong, long-standing ties with Korean customers.